SPY414.92-5.67 -1.35%
DIA332.96-5.20 -1.54%
IXIC14,030.38-130.97 -0.92%

Interpace Diagnostics Gr Q1 Adj. EBITDA Loss $900K vs Loss $4.3M In Same Qtr. Last Year, Sales $9.80M Up From $9.20M YoY

Interpace Diagnostics Gr (NASDAQ:IDXG) reported $9.80 million in sales this quarter. This is a 6.52 percent increase over sales of $9.20 million the same period last year.

05/11/2021 16:51
Interpace Diagnostics Gr (NASDAQ:IDXG) reported $9.80 million in sales this quarter. This is a 6.52 percent increase over sales of $9.20 million the same period last year.